| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S2213-8587(15)00121-7 |
| P698 | PubMed publication ID | 26179504 |
| P2093 | author name string | A Rogier T Donders | |
| Luc Noyez | |||
| Peter Pickkers | |||
| Gerard A Rongen | |||
| Niels P Riksen | |||
| Coert J Zuurbier | |||
| Rianne Nederlof | |||
| Hendrik-Jan Dieker | |||
| Marieke J Coenen | |||
| Saloua El Messaoudi | |||
| Henry A van Swieten | |||
| Annemieke Vos | |||
| P2860 | cites work | Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning | Q26995004 |
| Use and abuse of HOMA modeling | Q28263292 | ||
| Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era | Q28303142 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials | Q34349214 | ||
| Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening | Q34725613 | ||
| Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. | Q34964594 | ||
| Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study | Q35155185 | ||
| The diabetic heart: too sweet for its own good? | Q35810679 | ||
| Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease | Q36782688 | ||
| Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart | Q37686277 | ||
| Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery | Q37838146 | ||
| The cardioprotective effects of metformin | Q37928363 | ||
| Cardioprotection: chances and challenges of its translation to the clinic | Q38055280 | ||
| Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial | Q38433159 | ||
| Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon. | Q42516922 | ||
| Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans. | Q44261013 | ||
| Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery | Q44599811 | ||
| Ischemic postconditioning in pigs: no causal role for RISK activation. | Q46225223 | ||
| Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling | Q46847423 | ||
| Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction | Q47196867 | ||
| Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. | Q47833302 | ||
| Perioperative management of diabetic patients: new controversies | Q47835459 | ||
| Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial | Q48572279 | ||
| Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. | Q51325737 | ||
| Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention. | Q54390666 | ||
| Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene | Q57317083 | ||
| Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model | Q71730243 | ||
| A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease | Q73069750 | ||
| Diabetes, metformin and lactic acidosis | Q82255641 | ||
| P433 | issue | 8 | |
| P921 | main subject | metformin | Q19484 |
| coronary artery bypass surgery | Q186020 | ||
| P304 | page(s) | 615-623 | |
| P577 | publication date | 2015-07-12 | |
| P1433 | published in | The Lancet: Diabetes & Endocrinology | Q27725107 |
| P1476 | title | Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial. | |
| P478 | volume | 3 |
| Q36327207 | A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients. |
| Q41498937 | A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction |
| Q48957301 | Biomimicking Platelet-Monocyte Interactions as a Novel Targeting Strategy for Heart Healing. |
| Q59813541 | Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients |
| Q37586444 | Harnessing the early post-injury inflammatory responses for cardiac regeneration |
| Q57180762 | Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology |
| Q43236315 | High Dose Meclizine Prevents Renal Ischemia-Reperfusion Injury in Healthy Male Mice |
| Q48273941 | In response to: Metformin for the management of peri-operative hyperglycaemia |
| Q58804510 | Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery |
| Q37209499 | Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study |
| Q38338199 | Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction |
| Q85605784 | Metformin in cardiac surgery: high expectations |
| Q33743721 | Metformin is not associated with lactic acidosis in patients with diabetes undergoing coronary artery bypass graft surgery: a case control study |
| Q64092615 | New advances in perioperative cardioprotection |
| Q48302395 | Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial. |
| Q90703178 | Prognostic impact of elevated lactate levels on mortality in critically ill patients with and without preadmission metformin treatment: a Danish registry-based cohort study |
| Q38373147 | Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT. |
Search more.